JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas, April 11, 2025 – Two Air Force neurologists at Brooke Army Medical Center specialize in movement disorders including Parkinson’s disease. Parkinson's ...
Research from Carnegie Mellon University’s Aryn Gittis and colleagues suggests the most recognizable symptoms of Parkinson's disease — tremor and slowed movement — result from disruptions in different ...
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia, a neurological movement disorder whose few treatment options leave a ...
University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of ...
VIENNA — The state’s first two-day symposium for Parkinson’s and Movement Disorders will be held today and Saturday at the Grand Central Church of Christ at 5805 Grand Central Ave. in Vienna. The ...
Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...
Patients with Parkinson’s disease rarely present to the clinic with the textbook signs — forward stooped posture, slow and rigid movements, or shuffling gait. Instead, the earliest indicators are ...
Regular exercise can help people with Parkinson’s disease support mobility, function, and overall well-being. A balanced exercise routine for Parkinson’s often includes gait and balance training, ...
For the roughly 8.5 million people worldwide living with Parkinson’s disease, levodopa is both lifeline and trap. The drug ...
Researchers from the Broad Institute and Mass General Brigham have shown that a low-oxygen environment—similar to the thin air found at Mount Everest base camp—can protect the brain and restore ...
Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new insights ...